NCT06652815

Brief Summary

Deficits of executive function, meta cognition and stigma is known in suicidal ideation; however, their relationship is unknown. Since many studies use a single indicator of executive function and, it was considered important to study. Metacognition, executive functioning and stigma are the possible driving force behind the suicidal behavior in human being. With respect to research in the Indian context, there is paucity of studies exploring these factors. The purpose of the present study is to explore the relationships between executive functioning, metacognition, and stigma in suicidal ideation and suicide attempters in the Indian setup, where there is a lacuna in research regarding the same. Having a detailed understanding of these psychological parameters will be helpful in suicide prevention and management.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
16mo left

Started Dec 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 22, 2024

Completed
2.1 years until next milestone

Study Start

First participant enrolled

December 1, 2026

Expected
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2028

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

1.1 years

First QC Date

October 16, 2024

Last Update Submit

March 23, 2026

Conditions

Keywords

Suicide attemptMetacognitionsuicide ideationExecutive function

Outcome Measures

Primary Outcomes (3)

  • Metacognition measured by Metacognitions Questionnaire (MCQ-3) scores

    The Metacognitions Questionnaire-30 (MCQ-30) is a self-report measure that assesses metacognitive beliefs. The MCQ-30 is comprised of five factors. Responses are required on a four-point scale ranging from 1 (do not agree) to 4 (agree very much), high scores reflect more reported problems with the item in question.

    Within one week

  • Depression, Anxiety and Stress Scale-21 scores

    Depression, Anxiety and Stress Scale-21 Items (DASS-21): The Depression, Anxiety and Stress Scale - 21 Items (DASS-21) is a set of three self-report scales designed to measure the emotional states of depression, anxiety and stress. The anxiety scale assesses autonomic arousal, skeletal muscle effects, situational anxiety, and subjective experience of anxious affect. The stress scale is sensitive to levels of chronic nonspecific arousal. It assesses difficulty relaxing, nervous arousal, and being easily upset / agitated, irritable / over-reactive and impatient. Scores for depression, anxiety and stress are calculated by summing the scores for the relevant items.Higher scores mean more anxiety or depression and low scores means low anxiety or depression.

    Within one week

  • Stigma of Suicide Scale (SOSS) scores

    The Stigma of Suicide Scale is designed to assess stigmatizing attitudes of general community members toward people who suicide. The short form consists of 16 items. Each item consists of a one-word descriptor of a person who dies by suicide. We will use the short form. Each item is to be rated on a 5-point Likert scale from (1) strongly disagree to (5) strongly agree. Higher scores indicate higher levels of stigma towards people who suicide.

    Within one week

Study Arms (1)

Persons with suicide attempt or suicide ideation

Individuals with high suicide ideation or suicide attempts visiting ABVIMS -Dr. RML Hospital for treatment will be screened for this study.

Behavioral: Suicide ideation or suicide attempt

Interventions

Individuals with high suicide ideation or suicide attempts visiting ABVIMS -Dr. RML Hospital for treatment will be screened for this study. socio- demographics details will also be gathered. Following this Depression, Anxiety and Stress Scale (DASS-21), Wisconsin Card Sorting Test (WCST), Metacognitions Scale (MCQ-30) and Stigma of Suicide Scale (SOSS) will be administered.

Persons with suicide attempt or suicide ideation

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The present study is a cross sectional study. For the purpose of this study, individuals with suicidal ideation and attempts who are seeking treatment at the outpatient department of Psychiatry, as well as medical emergency of Dr. RML Hospital or referred to Department of Clinical Psychology would be approached to participate in the study.

You may qualify if:

  • Any gender
  • Age between 18 to 60 years.
  • Able to read and write in Hindi and English
  • With a primary mental health diagnosis of anxiety, depression, acute stress reaction or adjustment disorder, or with no diagnosis at all
  • Persons with high suicidal ideation (Score 2 or more in first five items of BSSI)
  • Person who attempted suicide in last three months.

You may not qualify if:

  • Any comorbid personality disorder diagnosis
  • Diagnosis of a major mental disorder such as Schizophrenia or Bipolar Affective Disorder.
  • Intellectual Disability and neurological disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Suicide, Attempted

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Vishwajit L Nimgaonkar, MD, PhD

    University of Pittburgh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Triptish Bhatia, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 16, 2024

First Posted

October 22, 2024

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

March 31, 2028

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

De-identified individual participant data collected during the trial as well as protocol will be shared on request at 1-2 years after article publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After one year of publication of results of the study.
Access Criteria
Study should be ethically approved and scientifically sound.